Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm Derived Pancreatic Cancer: A Multicenter Retrospective Analysis.
Habib JR, Rompen IF, Kaslow SR, Grewal M, Andel PCM, Zhang S, Hewitt DB, Cohen SM, van Santvoort HC, Besselink MG, Molenaar IQ, He J, Wolfgang CL, Javed AA, Daamen LA. Habib JR, et al. Ann Surg. 2024 Apr 12:10.1097/SLA.0000000000006295. doi: 10.1097/SLA.0000000000006295. Online ahead of print. Ann Surg. 2024. PMID: 38606874
Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived PDAC: An International Multicenter Study.
Habib JR, Rompen IF, Kinny-Köster B, Campbell BA, Andel PCM, Sacks GD, Billeter AT, van Santvoort HC, Daamen LA, Javed AA, Müller-Stich BP, Besselink MG, Büchler MW, He J, Wolfgang CL, Molenaar IQ, Loos M. Habib JR, et al. Ann Surg. 2024 Sep 12. doi: 10.1097/SLA.0000000000006532. Online ahead of print. Ann Surg. 2024. PMID: 39263741
[No title available]
[No authors listed] [No authors listed] PMID: 39271566
Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: An International Multicenter Study.
Habib JR, Javed AA, Rompen IF, Hidalgo Salinas C, Sorrentino A, Campbell BA, Andel PCM, Groot VP, Lafaro KJ, Sacks GD, Billeter AT, Molenaar IQ, Müller-Stich BP, Besselink MG, He J, Wolfgang CL, Daamen LA. Habib JR, et al. Ann Surg Oncol. 2024 Dec 12. doi: 10.1245/s10434-024-16649-z. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39666193
ASO Visual Abstract: Defining and Predicting Early Recurrence for Optimal Treatment Strategies in Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer--An International Multicenter Study.
Habib JR, Javed AA, Rompen IF, Salinas CH, Sorrentino A, Campbell BA, Andel PCM, Groot VP, Lafaro KJ, Sacks GD, Billeter AT, Molenaar IQ, Müller-Stich BP, Besselink MG, He J, Wolfgang CL, Daamen LA. Habib JR, et al. Ann Surg Oncol. 2025 Jan 4. doi: 10.1245/s10434-024-16794-5. Online ahead of print. Ann Surg Oncol. 2025. PMID: 39755887 No abstract available.
Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Reveals KRAS G12D and Mutant TP53 Combination as an Independent Predictor of Clinical Outcome.
Shoucair S, Habib JR, Pu N, Kinny-Köster B, van Ooston AF, Javed AA, Lafaro KJ, He J, Wolfgang CL, Yu J. Shoucair S, et al. Among authors: habib jr. Ann Surg Oncol. 2022 Apr;29(4):2720-2731. doi: 10.1245/s10434-021-11081-z. Epub 2021 Nov 18. Ann Surg Oncol. 2022. PMID: 34792696
A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cells After Resection of Pancreatic Ductal Adenocarcinoma.
Javed AA, Floortje van Oosten A, Habib JR, Hasanain A, Kinny-Köster B, Gemenetzis G, Groot VP, Ding D, Cameron JL, Lafaro KJ, Burns WR, Burkhart RA, Yu J, He J, Wolfgang CL. Javed AA, et al. Among authors: habib jr. Ann Surg. 2023 Jun 1;277(6):866-872. doi: 10.1097/SLA.0000000000005710. Epub 2022 Sep 15. Ann Surg. 2023. PMID: 36111839
89 results